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ABSTRACT 
 
 Vascular hamartomas (VH) are tumor like growths that typically appear in 
infants and manifest as a blemish on the skin. The goal of this study is to 
substantiate clinical data on the demographic characteristics and discover comorbid 
conditions associated with VH. Previous clinical data suggests that VH are associated 
with preterm birth. This study will be using two data sources: the nationally-
representative National Hospital Discharge Survey (NHDS) and Cerner Health Facts 
(HF). NHDS contained 2,944,459 patient discharges with a weighted total of 
386,186,183 and HF contained 46,721,119 unique patient IDs. Survey regressions 
were run for the NHDS data on vascular hamartoma patients and a series of 55 ICD-
9 CM codes with a frequency of 5 or higher in vascular hamartoma patients in the 
NHDS. Logistic regressions were run on the HF dataset for vascular hamartoma 
patients and the same set of 55 ICD-9 CM codes. Race, sex, region, and age were 
evaluated as predictors. The results show age as a significant negative predictor. 
Blacks and Asian/Pacific Islanders were significantly less likely to have VH than 
whites. Female subjects were more likely to have VH than males and patients in the 
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Northeast, Midwest, and West were significantly less likely to have VH than patients 
in the South. There were 13 significant comorbidities in the NHDS and 35 significant 
in HF. In both datasets 11 ICD-9 CM codes were found to be significantly associated 
with the diagnosis of VH. The demographics found in this analysis reflect previous 
clinical data and offer a population wide view of VH. The comorbidities show that VH 
may be associated with over development of the fetus.   
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CHAPTER 1 
INTRODUCTION 
Vascular hamartomas (VH) are benign, tumor-like growths that typically 
develop in infancy, are usually dermal, and consist of primitive to well-formed blood 
vessels. VH consist of three major diagnoses: port-wine stains, strawberry nevi, and 
birthmarks (World Health Organization, 2015e).  VH are relatively common, but 
despite this, little is known about comorbid associations or potential disease 
complications that could arise in vascular hamartoma patients.  
Port-wine stains are cutaneous capillary malformations and usually involve 
the head and neck. Port-wine stains occur in 3 out of 1000 newborns. They appear 
red and darken over the years (Shirley et al., 2013). Port-wine stains are found in a 
few combined vascular diseases such as Sturge-Weber Syndrome and Klippel-
Trenaunay Syndrome (Eerola et al., 2003). Port-wine stains’ most prevalent 
complication is emotional problems related to their appearance. There is an 
association with glaucoma if the port-wine stain is located on the eyelid (Berman, 
2015). Port-wine stains are associated with two genes, but the cause of birthmarks 
and strawberry nevi are mostly unknown (Cleveland Clinic, n.d.; Darrow, Greene, 
Mancini, & Nopper, 2015; Shirley et al., 2013). The gene GNAQ has been found as a 
cause of port-wine stains. A mutated version of RASA1 has also been found in 
patients with port-wine stains (Eerola et al., 2003; Shirley et al., 2013). Port-wine 
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stains clinically have been shown to affect males and females equally and be more 
common in whites than African Americans (Antaya, 2014).  
Strawberry nevi, also known as infantile hamartomas, are the most common 
tumors in children. They tend to resolve without intervention. Strawberry nevi’s 
complications are pain, functional impairment, or disfigurement (Aderibigbe, Treat, 
& Maguiness, 2015). Darrow, Greene, Mancini, & Nopper (2015) state that 
strawberry nevi occur in 5% of children, occur 1.4 to 3 times more often in females, 
and have the risk factors “white race, prematurity, low birth weight, advanced 
maternal age, multiple gestation pregnancy, placenta previa, and preeclampsia” (p. 
787). The pathogenesis is unknown. The cause is thought to be a mix of intrinsic 
factors such as angiogenic and vasculogenic factors and extrinsic factors  such as 
tissue hypoxia and developmental field disturbance (Darrow et al., 2015).  
The generic term birthmark can be classified as a vascular hamartoma, but 
many birthmarks, such as café au lait spots and Mongolian spots, don’t classify as 
VH. The cause of most birthmarks aren’t known but some can be hereditary 
(Cleveland Clinic, 2013; U.S. National Library of Medicine, 2014). 
The databases being used for this analysis are the National Hospital 
Discharge Survey (NHDS) and Health Facts (HF). Previously, most vascular 
hamartoma demographic information and comorbidities have been gathered 
clinically. The NHDS and HF should provide a broader, population basis, for 
understanding VH. The NHDS has been conducted annually since 1965 by the Center 
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for Disease Control (CDC) and the National Center for Health Statistics (NCHS). The 
goal of the NHDS is to meet the need for information on the characteristics of 
patients discharged from non-federal short-stay hospitals in the U.S. (Center for 
Disease Control, 2015). The dataset contains a variety of information such as 
discharge status, marital status, length of stay, and procedure codes (National 
Center for Health Statistics, 2010).  
Health Facts is provided to UMKC from Cerner through a collaboration with 
Truman Medical Center. The data in HF comes from the electronic medical records 
of hospitals that have a data use agreement with Cerner. The HF dataset contains a 
large variety of encounters with each patient receiving an unique identifier. Each 
encounter or hospital visit is associated with the patient’s identifier, sex, race, 
region, age, ICD-9 CM codes, and more. Cerner Corporation has established Health 
Insurance Portability and Accountability Act-compliant operating policies to 
establish de-identification for Health Facts. 
This approach was modeled after genome wide association studies (GWAS). 
GWAS examine hundreds of thousands of single-nucleotide polymorphisms (SNPs) 
for association with a disease in thousands of patients. The main goal of GWAS are 
to gather a large number of patients with the disease being examined and sequence 
their genomes. The genome of the patients are then compared against a reference 
genome or set of controls. P-values and odds ratios are then found for each SNP. 
Typically a chi-square or logistic regression is computed for each SNP and an alpha 
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correction is applied to the analysis to account for the multiple testing issue (Bush & 
Moore, 2012). Associated SNPs can help localize disease-causing genes. As the 
proximity of the SNP to a disease-causing gene shortens, the SNP will segregate with 
the causative gene. This can help lead to a cure or better understanding of a disease. 
Similarly, a single disease can have an effect on many different parts of the body and 
interact and be associated with many different diagnoses. Type I and type II 
polyglandular autoimmune (PGA) syndrome is an example of a disease that is 
associated with other threatening comorbidities. PGA syndrome is caused by 
damaged adrenal glands and is associated with hepatitis, juvenile anemia, diabetes, 
and more (Neufeld, Maclaren, & Blizzard, 1981). While VH are typically thought to 
be benign, understanding diseases associated with VH could show underlining 
mechanisms and potentially dangerous diseases that occur with VH.   
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CHAPTER 2 
METHODOLOGY 
 
 This analysis included ten years of NHDS data from 2001-2010. A new 
variable was created to indicate that a patient had a vascular hamartoma diagnosis. 
The ICD-9 CM Code 757.32 codes for VH and was used to create the vascular 
hamartoma variable. SAS 9.4, from the SAS institute, was the statistical program 
used for this analysis. The data was first imported into SAS using the code provided 
by the NHDS. The ten years of data was combined and then diagnosis variables were 
cleaned and reformatted with Stata.  
In the NHDS, hospitals are selected based on their number of annual beds 
and discharged patients. Hospitals with the most beds and discharges are selected 
with certainty. The remaining are sampled using a three-stage stratified design. The 
data collection is a two-step process starting with hospital staff or U.S. Bureau staff 
manually abstracting hospital records. The next step involves automatically 
purchasing hospital data from commercial organizations, state data systems, 
hospitals, or hospital associations (Dennison & Pokras, 2000). An important note 
about the NHDS is that the data includes a weight variable. The NHDS is created 
from a small sampling of all hospitals in the United States. In order to inflate records 
to national or regional estimates the NHDS requires the use of the weight variable. 
The NHDS states, “to produce an estimate of the number of discharges, the weights 
for the desired records must be summed” (12). The CDC calculates weight estimates 
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based on the 2000 U.S. census. Also, starting in 2010 the number of diagnosis codes 
was increased from seven to fifteen and due to funding the number of hospitals 
polled were reduced (National Center for Health Statistics, 2010). The reduction of 
hospitals resulted in an increase in the variability of the weight variable. 
A survey logistic regression was performed on the NHDS demographic 
variables race, sex, region, and age (table 1). In the NHDS the variable age originally 
consisted of two variables but was condensed for this analysis. The first variable 
indicated whether age was in days, months, or years and the second variable was 
the age of the patient. These two variables were used to create age in years. The 
regression was modeled for patients having VH with the demographic variables 
being used as effects. Race, sex, and region were treated categorically and age was 
treated as a continuous variable. Race consisted of white, black, American 
Indian/Alaskan Native, Asian, Native Hawaiian/Other Pacific Islander, and other. The 
census regions are West, South, Midwest, and Northeast. Whites were the reference 
for race, males were the reference for sex, and South was the reference for region. 
In the NHDS dataset the variable race included the categories multiple race and not 
stated. Patients that contained the race categories multiple race and not stated 
made up 28% of the data and were not used in this regression analysis because of 
their ambiguity. Results of the demographic regression can be seen on table 2. 
Unlike HF, the NHDS dataset did not have a Hispanic race category. 
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An additional analysis involved comparing comorbidities between patients 
with VH and patients without VH using a survey logistic regression. Vascular 
hamartoma patients had a total of 345 unique ICD-9 CM codes. Any ICD-9 CM code 
that did not appear in 5 or more vascular hamartoma patients were not used in the 
analysis decreasing the total to 55 unique ICD-9 CM codes. Any patient from the 
main dataset that did not have at least one of the 55 ICD-9 CM codes found in 
vascular hamartoma patients were removed from the dataset. After removing 
patients there were 64,573,269 weighted patients in the NHDS dataset. A survey 
logistic regression was run for each of the 55 ICD-9 CM codes using VH as the 
outcome, one of the ICD-9 CM codes as the effect, and age, race, and sex as the 
confounders. These variables were chosen as confounders based on results from the 
first regression examining demographic characteristics. The p-value used to indicate 
significance was 0.000909. This p-value was chosen to account for the multiple 
testing issue and was derived from a standard p-value (0.05) divided by 55.   
A logistic regression in HF was performed for the demographics in a similar 
manner as the NHDS dataset. Only unique patient IDs provided by HF were included 
in the analysis. The race category included white, black, Asian/Pacific Islander, 
Hispanic, and other. HF contained Asian and Asian/Pacific islander but these were 
condensed into a single group for this analysis. The groups Native American, other, 
biracial, and Mid-Eastern Indian were also condensed into a single group called 
“other”. Patients with the race categories NULL, Not Mapped, Null, and Unknown 
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were not used for this analysis and made up 5.2% of the data. Patients with the sex 
categories NULL, Not Mapped, Null, other, and Unknown/Invalid were not used in 
this analysis and comprised 0.02% of the data. The categories excluded from the 
analysis were removed because of their ambiguity. 
A logistic regression was run for each of the 55 ICD-9 CM codes in HF in the 
same manner as the NHDS. Any patient that did not have at least one of the 55 ICD-
9 CM codes was removed from the dataset and the same alpha (0.000909) was 
used. After removing patients that did not have at least one of the 55 ICD-9 CM 
codes there were 3,821,992 patients in the HF dataset used to analyze 
comorbidities.  
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CHAPTER 3 
RESULTS 
The NHDS dataset had a total of 2,944,459 observations with a weighted 
total of 386,186,183. Within the dataset there was a total of 1188 patients with VH 
and a weighted total of 162,859. The Health Facts data contained 46,721,119 total 
patients with 7488 vascular hamartoma patients. Figure 1 shows the flow of the 
analysis and table 1 contains the descriptive statistics for the demographic variables. 
An appropriate univariate analysis was run on each demographic.  
 
Figure 1.—Analysis flowchart 
 
 
 
Table 2 contains the significant results from the demographic regressions. 
For the NHDS data age was significantly associated with VH (OR=0.90, CI=0.89-0.90, 
P<0.0005). Blacks when compared to whites were almost two times less likely to 
have VH (OR=0.52, CI=0.38-0.71, P<0.0005). Females were 29% more likely to have 
VH than males (OR=1.29, CI=1.04-1.62, P=0.024). Patients from the Midwest were 
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more than two times less likely to have VH than those from the South (OR=0.44, 
CI=0.29-0.67, P<0.0005). Northeast patients were 64% less likely to have VH 
(OR=0.61, CI=0.44-0.84, P=0.003) and patients from the West were 89% less likely to 
have VH than those from the south (OR=0.53, CI=0.38-0.73, P<0.0005). 
In Health Facts age was a significant predictor (OR=0.92, CI=0.92-0.92, 
P<0.0005). Blacks were 67% less likely to have VH (OR=0.60, CI=0.56-0.65, 
P<0.0005), Asian/Pacific Islanders were 27% more likely to have VH (OR=1.27, 
CI=1.09-1.48, P=0.003) and the category other was 41% more likely to have VH than 
whites (OR=1.41, CI=1.31-1.52, P<0.001). Females were 28% more likely to have VH 
than males (OR=1.28, CI=1.22-1.34, P<0.0005). The regions Midwest (OR=0.65, 
CI=0.60-0.69, P<0.0005), Northeast (OR=0.70, CI=0.66-0.75, P<0.0005), and West 
(OR=0.60, CI=0.55-0.65, P<0.0005) were all less likely to have VH than the south.  
Table 3 contains the significant comorbidities for the individual logistic 
regressions using the 55 ICD-9 CM codes. Diagnoses that were significant in both 
datasets were esophageal reflux, congenital pigmentary anomalies of skin, other 
hamartoses (not elsewhere classified), other injuries to scalp, respiratory distress 
syndrome in newborn, septicemia [sepsis] of newborn, cutaneous hemorrhage of 
fetus or newborn, hemolytic disease of fetus or newborn due to ABO 
isoimmunization, congenital hydrocele, other specified conditions involving the 
integument of fetus and newborn, and single liveborn (born in hospital) and 
delivered without mention of cesarean section. The raw results in both datasets 
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were similar, but certain diagnoses found only in children and specific genders were 
different. In table 3 and 4 the bold rows indicate ICD-9 CM codes that were 
significant in both datasets. 
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Table 1.—Descriptive statistics and univariate analysis for NHDS (2001-2010) and HF 
(2000-2014) datasets 
 
Variable No VH VH P-value 
National Hospital Discharge Survey 
N (weighted) 2944459 (386186183) 1188 (162859)  
Age (years), mean (SD) 47.4 (323.5) 2.8 (80.0) <.0005 
Race    
       White 233021568 (78.0%) 102815 (80.0%) <.0005 
       Black 48042728 (16.1%) 14538 (11.3%)  
 American 
Indian/Alaskan Native 
1655827 (0.5%) 1219 (0.9%)  
       Asian 6118568 (2.0%) 4203 (3.3%)  
Native Hawaiian/Other 
Pacific Islander 
843152 (0.3%) 609 (0.5%)  
       Other 9030105 (3.0%)) 5268 (4.1%)  
Sex    
       Male 159207399 (41.2%) 68444 (42.0%) <.0005 
       Female 226815925 (58.8%) 94415 (56.0%)  
Region    
       Northeast 80671716 (20.9%) 26827 (16.5%) <.0005 
       South 145026956 (37.6%) 83202 (51.1%)  
       Midwest  86170975 (22.3%) 22509 (13.8%)  
       West 74153677 (19.2%) 30321 (18.6%)  
Health Facts 
N 46721119 7488  
Age (years), mean (SD) 45.4 (25.3)  12.3 (25.6) <.0005 
Race    
       White 31945304 (72.2%) 4378 (63.7%) <.0005 
       Black 7671539 (17.3%) 1042 (15.2%)  
       Hispanic 1445333 (3.3%) 415 (6.0%)  
       Asian/Pacific Islander 789567 (1.8%) 168 (2.4%)  
       Other 2424068 (5.5%) 874 (12.7%)  
Sex    
       Male 18951205 (40.6%) 3114 (41.6%) 0.067 
       Female 27757030 (59.4%) 4369 (58.4%)  
Region    
       Northeast 18122064 (38.8%) 2358 (31.5%) <.0005 
       South 11917102 (25.5%) 2511 (33.5%)  
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Table 1.—Continued 
 
Midwest 11129540 (23.8%)  1506 (20.2%)  
West  5508195 (11.8%)  1111 (14.8%)  
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Table 2.—Logistic regression results for the demographics using NHDS and Health 
Facts data 
 
 
Variable Reference Odds Ratio CI 
National Hospital Discharge Survey 
Age (years)  0.90 0.89-0.90 
Race    
       Black White 0.52 0.38-0.71 
Sex    
       Female Male 1.29 1.04-1.62 
Region    
       Midwest South 0.44 0.29-0.67 
       Northeast South 0.61 0.44-0.84 
       West South 0.53 0.38-0.73 
Health Facts 
Age (years)  0.92 0.92-0.92 
Race    
       Black White 0.60 0.56-0.65 
       Asian/Pacific Islander White 1.27 1.09-1.48 
       Other White 1.41 1.31-1.52 
Sex    
       Female Male 1.28 1.22-1.34 
Region    
       Midwest South 0.65 0.60-0.69 
       Northeast South 0.70 0.66-0.75 
       West South 0.60 0.55-0.65 
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Table 3.—Regression analysis of comorbidities in vascular hamartoma patients from 
NHDS and Health Facts datasets 
 
ICD-9 
Codes 
Label Odds 
Ratios 
HF 
Odds 
Ratios 
NHDS 
P-values 
HF 
P-
values 
NHDS 
216.1 Benign neoplasm of eyelid, 
including canthus 
1.67 32.04 0.1468 <.00005 
228.01 Hemangioma of skin and 
subcutaneous tissue 
9.69 1.11 <.00005 0.9026 
530.81 Esophageal reflux 0.06 0.00 <.00005 <.00005 
745 .5 Ostium secundum type atrial 
septal defect 
0.57 0.21 <.00005 0.0027 
752.51 Undescended testis 0.52 0.99 <.00005 0.9871 
757.33 Congenital pigmentary 
anomalies of skin 
6.56 7.61 <.00005 <.00005 
757.39 Other specified congenital 
anomalies of skin 
2.32 3.19 <.00005 0.0255 
759.6 Other hamartoses, not 
elsewhere classified 
24.32 8.15 <.00005 <.00005 
763.82 Abnormality in fetal heart rate 
or rhythm during labor 
2.11 0.69 <.00005 0.5253 
765.29 37 or more completed weeks of 
gestation 
1.48 0.39 <.00005 0.0806 
766.1 Other "heavy-for-dates" infants 2.24 1.29 <.00005 0.3505 
766.21 Post-term infant 3.04 1.88 <.00005 0.3921 
767.19 Other injuries to scalp 3.80 5.91 <.00005 <.00005 
767.3 Other injuries to skeleton due to 
birth trauma 
2.02 9.58 0.1624 0.0002 
769 Respiratory distress syndrome 
in newborn 
0.39 0.02 <.00005 <.00005 
770.83 Cyanotic attacks of newborn 1.99 0.41 0.0001 0.2258 
771.81 Septicemia [sepsis] of newborn 0.30 0.06 <.00005 <.00005 
772.6 Cutaneous hemorrhage of fetus 
or newborn 
5.38 2.93 <.00005 0.0004 
773.1 Hemolytic disease of fetus or 
newborn due to ABO 
isoimmunization 
1.68 0.14 0.0001 <.00005 
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Table 3.— Continued  
 
774.2 Neonatal jaundice associated 
with preterm delivery 
0.52 0.19 <.00005 0.0308 
774.6 Unspecified fetal and neonatal 
jaundice 
1.77 1.18 <.00005 0.3086 
775 .0 Syndrome of 'infant of a diabetic 
mother' 
1.62 1.18 <.00005 0.8068 
778.6 Congenital hydrocele 4.20 7.06 <.00005 <.00005 
778.8 Other specified conditions 
involving the integument of 
fetus and newborn 
4.17 6.01 <.00005 <.00005 
779.84 Meconium staining 2.32 0.19 <.00005 0.0033 
779.89 Other specified conditions 
originating in the perinatal 
period 
5.85 1.94 <.00005 0.0105 
785 .2 Undiagnosed cardiac murmurs 0.68 1.02 <.00005 0.9588 
910.0 Abrasion or friction burn of face, 
neck, and scalp except eye, 
without mention of infection 
0.20 1.84 <.00005 0.1838 
V05.3 Need for prophylactic 
vaccination and inoculation 
against viral hepatitis 
2.38 0.83 <.00005 0.2206 
V05.9 Need for prophylactic 
vaccination and inoculation 
against unspecified single 
disease 
1.79 0.95 <.00005 0.9023 
V20.1 Other healthy infant or child 
receiving care 
0.92 0.00 0.7821 <.00005 
V20.2 Routine infant or child health 
check 
0.30 0.97 <.00005 0.9341 
V29.0 Observation for suspected 
infectious condition 
1.78 0.51 <.00005 0.1025 
V30.00 Single liveborn, born in hospital, 
delivered without mention of 
cesarean section 
1.83 0.64 <.00005 0.0001 
V30.01 Single liveborn, born in hospital, 
delivered by cesarean section 
1.47 0.76 <.00005 0.0459 
V50.2 Routine or ritual circumcision 1.76 1.97 <.00005 0.1657 
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Table 3.—Continued 
 
V64.05 Vaccination not carried out 
because of caregiver refusal 
2.07 0.61 <.00005 0.3671 
V72.19 Other examination of ears and 
hearing 
0.57 0.74 0.0007 0.6112 
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Table 4.—Frequency and percent of total for ICD-9 CM codes in NHDS and HF 
databases  
 
ICD-9 
Codes 
Label Frequency 
HF 
Frequency 
NHDS 
216.1 Benign neoplasm of eyelid, including canthus 4161 
(0.11%) 
9817 
(0.02%) 
228.01 Hemangioma of skin and subcutaneous tissue 17493 
(0.46%) 
90712 
(0.14%) 
530.81 Esophageal reflux 1777978 
(46.52%) 
22130623 
(34.27%) 
745 .5 Ostium secundum type atrial septal defect 70822 
(1.85%) 
888613 
(1.38%) 
752.51 Undescended testis 24888 
(0.65%) 
192801 
(0.3%) 
757.33 Congenital pigmentary anomalies of skin 18782 
(0.49%) 
404283 
(0.63%) 
757.39 Other specified congenital anomalies of skin 13197 
(0.35%) 
106045 
(0.16%) 
759.6 Other hamartoses, not elsewhere classified 3352 
(0.09%) 
33194 
(0.05%) 
763.82 Abnormality in fetal heart rate or rhythm 
during labor 
7928 
(0.21%) 
119382 
(0.18%) 
765.29 37 or more completed weeks of gestation 43683 
(1.14%) 
798554 
(1.24%) 
766.1 Other "heavy-for-dates" infants 38846 
(1.02%) 
2070341 
(3.21%) 
766.21 Post-term infant 26497 
(0.69%) 
404237 
(0.63%) 
767.19 Other injuries to scalp 17622 
(0.46%) 
579325 
(0.9%) 
767.3 Other injuries to skeleton due to birth trauma 561 
(0.01%) 
50401 
(0.08%) 
769 Respiratory distress syndrome in newborn 21031 
(0.55%) 
1104559 
(1.71%) 
770.83 Cyanotic attacks of newborn 4582 
(0.12%) 
130496 
(0.2%) 
771.81 Septicemia [sepsis] of newborn 19690 
(0.52%) 
792410 
(1.23%) 
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Table 4.-- Continued 
 
772.6 Cutaneous hemorrhage of fetus or newborn 8768 
(0.23%) 
371994 
(0.58%) 
773.1 Hemolytic disease of fetus or newborn due 
to ABO isoimmunization 
9123 
(0.24%) 
566385 
(0.88%) 
774.2 Neonatal jaundice associated with preterm 
delivery 
31325 
(0.82%) 
1787018 
(2.77%) 
774.6 Unspecified fetal and neonatal jaundice 157544 
(4.12%) 
5870438 
(9.09%) 
775 .0 Syndrome of 'infant of a diabetic mother' 11082 
(0.29%) 
414817 
(0.64%) 
778.6 Congenital hydrocele 6282 
(0.16%) 
247432 
(0.38%) 
778.8 Other specified conditions involving the 
integument of fetus and newborn 
23953 
(0.63%) 
574382 
(0.89%) 
779.84 Meconium staining 11504 
(0.3%) 
197671 
(0.31%) 
779.89 Other specified conditions originating in the 
perinatal period 
47429 
(1.24%) 
889323 
(1.38%) 
785 .2 Undiagnosed cardiac murmurs 175524 
(4.59%) 
849416 
(1.32%) 
910.0 Abrasion or friction burn of face, neck, and 
scalp except eye, without mention of 
infection 
110840 
(2.9%) 
356546 
(0.55%) 
V05.3 Need for prophylactic vaccination and 
inoculation against viral hepatitis 
307374 
(8.04%) 
12203956 
(18.9%) 
V05.9 Need for prophylactic vaccination and 
inoculation against unspecified single disease 
53597 
(1.4%) 
880319 
(1.36%) 
V20.1 Other healthy infant or child receiving care 3381 
(0.09%) 
13143 
(0.02%) 
V20.2 Routine infant or child health check 863498 
(22.59%) 
30545 
(0.05%) 
V29.0 Observation for suspected infectious 
condition 
65103 
(1.7%) 
2923442 
(4.53%) 
V30.00 Single liveborn, born in hospital, delivered 
without mention of cesarean section 
496243 
(12.98%) 
27400589 
(42.43%) 
V30.01 Single liveborn, born in hospital, delivered by 
cesarean section 
217060 
(5.68%) 
10808074 
(16.74%) 
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Table 4.-- Continued 
 
V50.2 Routine or ritual circumcision 38721 
(1.01%) 
344694 
(0.53%) 
V64.05 Vaccination not carried out because of 
caregiver refusal 
9821 
(0.26%) 
191205 
(0.3%) 
V72.19 Other examination of ears and hearing 22286 
(0.58%) 
818958 
(1.27%) 
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CHAPTER 4 
DISCUSSION 
 
 The NHDS and HF data provided a population wide look into vascular 
hamartoma patients. Previous clinical data has shown occurrences in patients 
anywhere between 0.3-5% (Darrow et al., 2015; Shirley et al., 2013). The data from 
the NHDS has an occurrence of ~0.04% and Health Facts has an occurrence of 
~0.02%. A possible reason for the low incidence rate is differential diagnoses. 
Birthmarks cover a wide variety of possible diagnoses with many having a different 
ICD-9 CM code (American Academy of Pediatrics, 2009). With the physical 
similarities between the different birthmarks, there is a possibility of misdiagnosis or 
miscoding. Strawberry nevi tend to resolve on their own and wouldn’t be 
documented in later visits. Also, older patients returning to the hospital are not 
likely to be re-diagnosed with a port-wine stain.  
The demographic characteristics in the NHDS and Health Facts typically 
reflect previous clinical data. Age was expected to be significantly different since a 
majority of cases of vascular hamartomas are diagnosed in infancy. Previous clinical 
data show that females are significantly more likely to have strawberry nevi and that 
port-wine stains and birthmarks affect both sexes evenly (Aderibigbe et al., 2015; J. 
Nelson, n.d.). Females are 29% more likely to have VH in the NHDS and are 28% 
more likely in HF. The increased likelihood of VH in females agrees with previous 
clinical data but 28-29% is not consistent with the 1.4-3.0 time increase seen 
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clinically in female strawberry nevi patients. The differences between this study and 
previous clinical data may be related to port-wine stains affecting both sexes 
equally.  
The regression analysis shows that blacks are almost two times less likely in 
the NHDS dataset and 67% less likely in the Health Facts dataset to have VH 
documented compared to white patients. In the Health Facts dataset Asian/Pacific 
Islanders were 27% more likely to have VH documented in their medical record 
compared to whites. Further analysis should be done to determine if Asians/Pacific 
Islanders are more likely to have VH. Previous studies have shown that port-wine 
stains and strawberry nevi were more common among whites than blacks (Amrock 
& Weitzman, 2013; Antaya, 2014).   
The datasets, NHDS and Health Facts, found similar racial tendencies, but 
disagreed in some areas. These differences could be attributed to the relative 
standard error (RSE) in the NHDS for people under 15 years of age. RSE is a measure 
of the sampling variability in the NHDS. Since the majority of patients with VH were 
less than 15 years of age, the RSE could be as high as 30% for whites and blacks. 
With a lack of understanding for the cause of vascular hamartomas, it is difficult to 
determine why race is significantly associated. With the cause of port-wines stains 
being traced to the GNAQ gene perhaps there is an underlining genetic disposition 
(Shirley et al., 2013).  
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There are few studies on the regional distribution of VH. The NHDS and 
Health Facts show that Midwest, West, and Northeast patients are all significantly 
less associated with VH than patients from the south. The NHDS and Health Facts 
are similar in this statistic with the NHDS showing a more negative association. It is 
worth noting that all regions in the NHDS had a RSE of at least 20%. The West had 
RSE of 35%, which is higher than the 30% recommended by the NHDS. If the cause 
of most vascular hamartomas are genetic, the regional distribution could easily be 
affected. The quality of health care is lower for southern states which might 
contribute to the increase of vascular hamartoma patients (U.S. Department of 
Health and Human Services, 2015).  
There were a variety of comorbidities found to be associated with VH. Most 
comorbidities positively associated with VH in both datasets can be broken down 
into three main categories: hemorrhaging/vascular, skin issues, and birth trauma. 
Other hamartomas, not elsewhere classified and cutaneous hemorrhage of fetus or 
newborn both show possible vascular issues (World Health Organization, 2015a, 
2015b). Congenital pigmentary anomalies of skin and other specified conditions 
involving the integument of fetus and newborn both involve diagnoses that affect 
the skin (World Health Organization, 2015b, 2015d). Other injuries to skeleton due 
to birth trauma is an example of birth trauma (World Health Organization, 2015c).  
Overdevelopment of the fetus’ physiology might connect the positively 
associated diagnoses. Overdevelopment is backed by the ICD-9 CM codes other 
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“heavy-for-dates” infants and post-term infants having an increased likelihood in 
both datasets and being significantly associated in Health Facts. This could mean 
that VH are linked to a growth factor in early development. One thing to note is that 
many of the skin conditions are possible differential diagnoses (A. Nelson et al., 
2007; Vorvick, 2015).  
The negatively associated comorbidities may have under development in 
common. This is supported by the ICD-9 CM code other preterm infants, 1,750-1,999 
grams being less associated in both datasets but not significant. Esophageal reflux, 
respiratory distress syndrome (RDS), undescended testicle, and ostium secundum 
type atrial septal defect are diagnoses that are caused by under development of a 
physiological feature. Esophageal reflux is caused by the lower esophageal sphincter 
not closing properly and RDS is caused by a lack of surfactant (a slippery substance 
in the lungs that aids in keeping the air sacs from deflating) (Lee, 2013; Subodh, 
2015). Ostium secundum type atrial septal defect is an opening in the wall of tissue 
that separates the left and right atria and is typically caused by an inadequate 
formation of the septum secundum (one of two major septal structures involved in 
partitioning the atrium) (Gessner, 2016). A few negatively associated comorbidities 
are also associated with infants being premature. Neonatal jaundice and septicemia 
[sepsis] of newborn are examples of diseases that occur more often in preterm 
infants (Hansen, Windle, & Carter, 2015; Lee, 2015).  
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Three results, congenital hydrocele, single liveborn (born in hospital) 
delivered without mention of cesarean section, and hemolytic disease of fetus or 
newborn due to ABO isoimmunization, don’t follow the pattern seen in this analysis 
or contain opposite associations for each dataset. Congenital hydrocele (778.6) 
contains a higher prevalence in preterm infants and is positively associated with VH. 
This is contrary to most results in this analysis. Congenital hydrocele is believed to 
be related to the amount of smooth muscle in the processus vaginalis and is six 
times more common in males (Ortenberg & Roth, 2014). Single liveborn (born in 
hospital) delivered without mention of cesarean section (V30.00) and hemolytic 
disease of fetus or newborn due to ABO isoimmunization (773.1) was significant in 
both datasets but positively associated in HF and negatively associated in the NHDS. 
The difference could be related to the RSE in the NHDS data. For this dataset the RSE 
for patients under 15 years of age is abnormally high and thus might affect the 
results. HF doesn’t rely on weighted estimates and is likely more reliable.  
The limitations with this research are related to the NHDS dataset. One 
limitation is that the NHDS does not recommend using data with less than 30 
unweighted observations. This was unavoidable during the comorbidity analysis. 
This would make the RSE for some of the comorbidities very high. The large RSE for 
the data increases the chance for a type I and type II error. Health Facts on the other 
hand does not suffer from RSE issues and many of the significant comorbidities 
found in the NHDS were also found in Health Facts. The use of ICD-9 CM codes are 
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also a limitation. Many ICD-9 CM codes cover quite a few diseases. This limits the 
precision of the analysis and what can be learned. The NHDS and HF are also 
completely reliant on physicians diagnosing correctly with no way to verify accuracy. 
Future studies, examining comorbidities in vascular hamartoma patients, 
should involve a more precise dataset that provides more granularity for the 
comorbidities. More granularity in the dataset could make connections more 
obvious and provide more details on possible mechanisms. While the use of ICD-10 
codes isn’t prevalent in U.S. hospitals, ICD-10 codes could provide a more detailed 
look at the comorbidities. Also if a large enough hospital system is available the EHR 
might prove beneficial for this study. Discovering the cause and effect of each 
comorbidity might also prove beneficial. Ascertaining from the data if VH is the 
cause of the comorbidity or if the comorbidity caused a vascular hamartoma is 
difficult. The number of diagnoses in vascular hamartoma patients compared to all 
other patients and the way physicians typically assign ICD-9 CM codes could be 
beneficial information. Future studies could also look into other ICD-9 CM codes 
since the methods in this research could apply to any code.  
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